Interventional and Structural Cardiologist. Dir. of Clinical and Outcomes Research, @crfheart. Director of Acad. Affairs, @StFrancis_LI. Die-hard Red Sox fan.
New York, NY
Joined October 2017
- Tweets33.1K
- Following697
- Followers19.8K
- Likes75.2K
David J. Cohen, MD, MSc retweeted
🌟 Be there when new data takes the #TCT2026 stage.
Iñigo Lozano, MD, PhD, will present the EPIC17-VERONICA late-breaker on Tuesday, November 3. Hear the findings firsthand and join the conversation around the latest cardiovascular science.
🔗 Explore the late-breaking program: ow.ly/zOor50ZYvzE
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
David J. Cohen, MD, MSc retweeted
Excited to share our new review in @crfshj with @kayla_chiew, @djc795, and @rallamee exploring the role and design of placebo-controlled trials in structural heart disease.
bit.ly/4z6AsFC
David J. Cohen, MD, MSc retweeted
Watch Now | OPCI Journal Club: SWITCH SWEDEHEART with @BjornRedfors and panelists @djc795 @ziadalinyc @ESHLOF @JWMoses @DrAllenJ. opci.live/opci-lives/switch-…
David J. Cohen, MD, MSc retweeted
One meeting. Endless possibilities. ✨
This is your ultimate #TCT2026 checklist. The only question is: How many will you check off? ✅🌴 ow.ly/qqFn50ZYy8z
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
David J. Cohen, MD, MSc retweeted
Excited to announce MIAMI LIVE 2026! 🌴🫀
Join us Dec 5 in Miami for an immersive, educational experience featuring live complex interventional cases, world-renowned faculty, cutting-edge imaging & AI, and debates on the latest innovations in the field.
📍 Loews Miami Beach Hotel
Register below
🔗 promedicacme.com/miami-live/
#MiamiLIVE2026 #InterventionalCardiology #PCI #Cardiology
@YChatzizisis
David J. Cohen, MD, MSc retweeted
⚡ Train with the experts. Master what's next.
Meet the renowned faculty leading the #TCT2026 Training Pavilions and discover the hands-on experiences, cutting-edge technologies, and practical skills that will elevate your practice. ow.ly/uYNa50ZWZh8
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @BernardBruyne
David J. Cohen, MD, MSc retweeted
🚀 We will have more than 50 hands-on training sessions at @TCTConference this year!
Join us across 5 dedicated Training Pavilions covering coronary imaging, physiology, PCI skills, and 2 for structural interventions.
Learn from the experts. Take your skills to the next level.
🔥 Not to be missed! #TCT2026
⚡ Train with the experts. Master what's next.
Meet the renowned faculty leading the #TCT2026 Training Pavilions and discover the hands-on experiences, cutting-edge technologies, and practical skills that will elevate your practice. ow.ly/uYNa50ZWZh8
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @BernardBruyne
David J. Cohen, MD, MSc retweeted
🦈 The sharks are circling... The TCT Shark Tank Finalists have officially been announced! 🚀
Watch 6️⃣ startups take the stage with bold ideas, breakthrough technologies, and one goal: winning a $200,000 prize, generously provided by the Jon DeHaan Foundation (@JHDHFoundation). Who will make the biggest splash at #TCT2026? ow.ly/JqG050ZWYxY
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost
David J. Cohen, MD, MSc retweeted
For low risk aortic stenosis, does valve replacement deliver lasting health, not just survival? Explore 7 year health outcomes after TAVR and SAVR in #JACC: bit.ly/3TRfds5
@ANVoraMD #CardioX
David J. Cohen, MD, MSc retweeted
2️⃣ roads, 1️⃣ destination: In PARTNER 3 (low surgical risk patients with AS), TAVR pts recovered faster vs SAVR, but by 7 yrs ~60% in both arms were alive w/ excellent health status (58.4% vs 61.7%, P=0.40). #JACC. @ppibarot @djc795 @hahn_rt @suzannevarnold bit.ly/4j9iqO4
David J. Cohen, MD, MSc retweeted
How often does redo AVR occur after TAVR? The answer may depend on how you calculate it—and who you’re calculating it for. See how Kaplan-Meier and cumulative incidence estimates diverge over time in #JACC: bit.ly/4hSfZgH
#CardioX #TAVR @djc795
David J. Cohen, MD, MSc retweeted
Watch OPCI Journal Club with Julinda Mehilli presenting "Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX." Panelists @djc795 @Dr_H_S_Gill @WallyOmarMD and Drs. Andrew Berke and Matthew Henry.
opci.live/opci-lives/transca…
David J. Cohen, MD, MSc retweeted
Thank you for a fantastic Division of Cardiology Grand Rounds at @UpstateNews, Dr. @djc795! We will have to get you back to Syracuse to spend more time with our fellows (by popular demand).
David J. Cohen, MD, MSc retweeted
⚡ What separates good outcomes from great ones? The right decisions.
At #TCT2026, explore real-world strategies, cutting-edge technologies, and expert perspectives transforming cardiovascular care every day.
🫀 Featured Session: Radiation Protection: Protecting Patients, Operators, and the Cath Lab Team (Mon., Nov. 2)
ow.ly/EW8j50ZVWef
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost
David J. Cohen, MD, MSc retweeted
📣 The finalists for the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award have been selected!
Recognizing rising physician-scientists who embody clinical excellence, academic achievement, and a passion for advancing cardiovascular care, the Linnemeier Award has helped launch the careers of many of today's leaders in #interventionalcardiology.
🏆 Meet the finalists and join us as we celebrate the next generation of innovators at #TCT2026! ow.ly/WSvQ50ZUHKe
#CardioX #CardioTwitter #CardioEd #CardioResearch @ChrisGBruce13 @nmbutala @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md
David J. Cohen, MD, MSc retweeted
🚀 Heading to #TCT2026? Make it official with a personalized social graphic!
Create yours in seconds and share your TCT experience with the global cardiovascular community. ow.ly/Cyni50ZUGU2
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md
David J. Cohen, MD, MSc retweeted
We don't ask whether a model touched their prose. We ask authors to own every word.
@JACCJournals parted w/ICMJE & doesn't require disclosure of AI writing help: the rule is unenforceable, biased, & not good for medical communication.
My Editor's Page: jacc.org/doi/10.1016/j.jacc.…
David J. Cohen, MD, MSc retweeted
Beyond the COAPT trial: Transportability suggests secondary mitral valve repair + optimized heart failure care could offer similar benefits in real-world practice. jacc.org/doi/10.1016/j.jacc.…
#JACC #COAPT #MTEER #HeartFailure @djc795 @GreggWStone @nmbutala @rwyeh @BahiraShahim
David J. Cohen, MD, MSc retweeted
Did CARDIO-TTRansform fail, or did it answer a different question? The effect of eplontersen depended on background stabilizer therapy.
New article at @opensourcecardiology walks through the monotherapy signal, the pooled silencer data, and why percent knockdown is harder to compare than it looks.
@BrettSperryMD @HamzahAliMD
opensourcecardiology.org/doi…
David J. Cohen, MD, MSc retweeted
Thank you @JACCJournals for publishing our study of 💰source and online & academic impact of major #Cardiovascular #RCTs @farbod_ZT @SinaRsh @MGBResearchNews @GreggWStone @Drroxmehran @hmkyale @lmhcurtis @djc795 @crfheart @kaulcsmc 👇
jacc.org/doi/10.1016/j.jacc.…
Positive CV trials get noticed—but does funding matter? Among 433 RCTs, Altmetric scores did not differ by funding source, while industry-sponsored trials were cited more frequently, driven largely by trials meeting their primary outcomes. jacc.org/doi/10.1016/j.jacc.… #JACC
